These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1316417)

  • 21. The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes.
    Tedeschi R; Foong YT; Cheng HM; dePaoli P; Lehtinen T; Elfborg T; Dillner J
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1393-400. PubMed ID: 7540196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.
    Hofmann B; Bass H; Nishanian P; Faisal M; Figlin RA; Sarna GP; Fahey JL
    Clin Exp Immunol; 1992 Jun; 88(3):548-54. PubMed ID: 1606739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic mononucleosis syndrome.
    DuBois RE; Seeley JK; Brus I; Sakamoto K; Ballow M; Harada S; Bechtold TA; Pearson G; Purtilo DT
    South Med J; 1984 Nov; 77(11):1376-82. PubMed ID: 6093268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
    Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T
    J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble CD4, CD8 and interleukin-2 receptor levels in patients with acute cytomegalovirus mononucleosis syndrome.
    Marcante R; Cavedon G
    Allergol Immunopathol (Madr); 1991; 19(3):99-102. PubMed ID: 1665953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum neopterin and interleukin-6 levels in chronic fatigue syndrome.
    Chao CC; Gallagher M; Phair J; Peterson PK
    J Infect Dis; 1990 Dec; 162(6):1412-3. PubMed ID: 2230278
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical symptoms and markers of disease mechanisms in adolescent chronic fatigue following Epstein-Barr virus infection: An exploratory cross-sectional study.
    Kristiansen MS; Stabursvik J; O'Leary EC; Pedersen M; Asprusten TT; Leegaard T; Osnes LT; Tjade T; Skovlund E; Godang K; Wyller VBB
    Brain Behav Immun; 2019 Aug; 80():551-563. PubMed ID: 31039432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell cytokine profile during primary Epstein-Barr virus infection (infectious mononucleosis).
    Attarbaschi T; Willheim M; Ramharter M; Hofmann A; Wahl K; Winkler H; Graninger W; Winkler S
    Eur Cytokine Netw; 2003; 14(1):34-9. PubMed ID: 12799212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.
    Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH
    J Immunol; 1986 May; 136(10):3636-42. PubMed ID: 3009608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequent double infection with Epstein-Barr virus and human herpesvirus-6 in patients with acute infectious mononucleosis.
    Bertram G; Dreiner N; Krueger GR; Ramon A; Ablashi DV; Salahuddin SZ; Balachandram N
    In Vivo; 1991; 5(3):271-9. PubMed ID: 1654150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.
    Weiss ER; Alter G; Ogembo JG; Henderson JL; Tabak B; Bakiş Y; Somasundaran M; Garber M; Selin L; Luzuriaga K
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27733645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recruitment during infectious mononucleosis of CD3+CD4+CD8+ virus-specific cytotoxic T cells which recognise Epstein-Barr virus lytic antigen BHRF1.
    White CA; Cross SM; Kurilla MG; Kerr BM; Schmidt C; Misko IS; Khanna R; Moss DJ
    Virology; 1996 May; 219(2):489-92. PubMed ID: 8638417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up.
    Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
    In Vivo; 2007; 21(5):707-13. PubMed ID: 18019402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of Epstein-Barr virus load and virus-specific CD8+ T cells in acute infectious mononucleosis.
    Hoshino Y; Nishikawa K; Ito Y; Kuzushima K; Kimura H
    J Clin Virol; 2011 Mar; 50(3):244-6. PubMed ID: 21185773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
    Andersson J
    Scand J Infect Dis Suppl; 1996; 100():72-82. PubMed ID: 8860357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
    Loebel M; Eckey M; Sotzny F; Hahn E; Bauer S; Grabowski P; Zerweck J; Holenya P; Hanitsch LG; Wittke K; Borchmann P; Rüffer JU; Hiepe F; Ruprecht K; Behrends U; Meindl C; Volk HD; Reimer U; Scheibenbogen C
    PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus effect on frequency of functionally distinct T cell subsets in children with infectious mononucleosis.
    Sulik A; Oldak E; Kroten A; Lipska A; Radziwon P
    Adv Med Sci; 2014 Sep; 59(2):227-31. PubMed ID: 25051418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load.
    Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A;
    J Infect Dis; 2006 Mar; 193(5):664-71. PubMed ID: 16453261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral interleukin-10 in chronic active Epstein-Barr virus infection.
    Kanegane H; Wakiguchi H; Kanegane C; Kurashige T; Tosato G
    J Infect Dis; 1997 Jul; 176(1):254-7. PubMed ID: 9207376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.